English
简体中文
Total: £ 56.28
Published Date: 2024-11-25 | Pages: 119 | Tables: 249 | Pharma & Healthcare
Coccidiosis is a parasitic disease of a wide variety of animals caused by coccidian protozoa. The disease spreads from one animal to another by contact with infected feces or ingestion of infected tissue. Diarrhea is the primary symptom of Coccidiosis. Coccidia can infect a wide variety of animals, including humans, birds, and livestock, as they are usually species-specific. The coccidia are responsible for major economic losses of the livestock industry.
The global market for Coccidiosis Treatment was estimated to be worth US$ 134 million in 2023 and is forecast to a readjusted size of US$ 167.4 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Coccidiosis Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Coccidiosis Treatment by region & country, by Type, and by Application.
The Coccidiosis Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coccidiosis Treatment.
Market Segmentation
By Company
Bayer Animal Health
Boehringer Ingelheim Vetmedica, Inc.
Ceva Sante Animale
Intas Pharmaceuticals Ltd.
Jurox Pty Ltd.
Merck Animal Health
Vetoquinol S.A.
Virbac S.A.
Zoetis, Inc.
Novartis Animal Healthcare
Smartvet Inc.
Huvepharma
Segment by Type:
Ionophore Drugs
Antibiotic Drugs
Chemical Derivative Drugs
Segment by Application
Poultry
Fish
Cattle
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Coccidiosis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Coccidiosis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Coccidiosis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Coccidiosis Treatment Product Introduction
1.2 Global Coccidiosis Treatment Market Size Forecast
1.2.1 Global Coccidiosis Treatment Sales Value (2019-2030)
1.2.2 Global Coccidiosis Treatment Sales Volume (2019-2030)
1.2.3 Global Coccidiosis Treatment Sales Price (2019-2030)
1.3 Coccidiosis Treatment Market Trends & Drivers
1.3.1 Coccidiosis Treatment Industry Trends
1.3.2 Coccidiosis Treatment Market Drivers & Opportunity
1.3.3 Coccidiosis Treatment Market Challenges
1.3.4 Coccidiosis Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Coccidiosis Treatment Players Revenue Ranking (2023)
2.2 Global Coccidiosis Treatment Revenue by Company (2019-2024)
2.3 Global Coccidiosis Treatment Players Sales Volume Ranking (2023)
2.4 Global Coccidiosis Treatment Sales Volume by Company Players (2019-2024)
2.5 Global Coccidiosis Treatment Average Price by Company (2019-2024)
2.6 Key Manufacturers Coccidiosis Treatment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Coccidiosis Treatment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Coccidiosis Treatment
2.9 Coccidiosis Treatment Market Competitive Analysis
2.9.1 Coccidiosis Treatment Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Coccidiosis Treatment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coccidiosis Treatment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ionophore Drugs
3.1.2 Antibiotic Drugs
3.1.3 Chemical Derivative Drugs
3.2 Global Coccidiosis Treatment Sales Value by Type
3.2.1 Global Coccidiosis Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Coccidiosis Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Coccidiosis Treatment Sales Value, by Type (%) (2019-2030)
3.3 Global Coccidiosis Treatment Sales Volume by Type
3.3.1 Global Coccidiosis Treatment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Coccidiosis Treatment Sales Volume, by Type (2019-2030)
3.3.3 Global Coccidiosis Treatment Sales Volume, by Type (%) (2019-2030)
3.4 Global Coccidiosis Treatment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Poultry
4.1.2 Fish
4.1.3 Cattle
4.2 Global Coccidiosis Treatment Sales Value by Application
4.2.1 Global Coccidiosis Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Coccidiosis Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Coccidiosis Treatment Sales Value, by Application (%) (2019-2030)
4.3 Global Coccidiosis Treatment Sales Volume by Application
4.3.1 Global Coccidiosis Treatment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Coccidiosis Treatment Sales Volume, by Application (2019-2030)
4.3.3 Global Coccidiosis Treatment Sales Volume, by Application (%) (2019-2030)
4.4 Global Coccidiosis Treatment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Coccidiosis Treatment Sales Value by Region
5.1.1 Global Coccidiosis Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Coccidiosis Treatment Sales Value by Region (2019-2024)
5.1.3 Global Coccidiosis Treatment Sales Value by Region (2025-2030)
5.1.4 Global Coccidiosis Treatment Sales Value by Region (%), (2019-2030)
5.2 Global Coccidiosis Treatment Sales Volume by Region
5.2.1 Global Coccidiosis Treatment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Coccidiosis Treatment Sales Volume by Region (2019-2024)
5.2.3 Global Coccidiosis Treatment Sales Volume by Region (2025-2030)
5.2.4 Global Coccidiosis Treatment Sales Volume by Region (%), (2019-2030)
5.3 Global Coccidiosis Treatment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Coccidiosis Treatment Sales Value, 2019-2030
5.4.2 North America Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Coccidiosis Treatment Sales Value, 2019-2030
5.5.2 Europe Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Coccidiosis Treatment Sales Value, 2019-2030
5.6.2 Asia Pacific Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Coccidiosis Treatment Sales Value, 2019-2030
5.7.2 South America Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Coccidiosis Treatment Sales Value, 2019-2030
5.8.2 Middle East & Africa Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Coccidiosis Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Coccidiosis Treatment Sales Value
6.2.1 Key Countries/Regions Coccidiosis Treatment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Coccidiosis Treatment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Coccidiosis Treatment Sales Value, 2019-2030
6.3.2 United States Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Coccidiosis Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Coccidiosis Treatment Sales Value, 2019-2030
6.4.2 Europe Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Coccidiosis Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Coccidiosis Treatment Sales Value, 2019-2030
6.5.2 China Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Coccidiosis Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Coccidiosis Treatment Sales Value, 2019-2030
6.6.2 Japan Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Coccidiosis Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Coccidiosis Treatment Sales Value, 2019-2030
6.7.2 South Korea Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Coccidiosis Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Coccidiosis Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Coccidiosis Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Coccidiosis Treatment Sales Value, 2019-2030
6.9.2 India Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Coccidiosis Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bayer Animal Health
7.1.1 Bayer Animal Health Company Information
7.1.2 Bayer Animal Health Introduction and Business Overview
7.1.3 Bayer Animal Health Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bayer Animal Health Coccidiosis Treatment Product Offerings
7.1.5 Bayer Animal Health Recent Development
7.2 Boehringer Ingelheim Vetmedica, Inc.
7.2.1 Boehringer Ingelheim Vetmedica, Inc. Company Information
7.2.2 Boehringer Ingelheim Vetmedica, Inc. Introduction and Business Overview
7.2.3 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Product Offerings
7.2.5 Boehringer Ingelheim Vetmedica, Inc. Recent Development
7.3 Ceva Sante Animale
7.3.1 Ceva Sante Animale Company Information
7.3.2 Ceva Sante Animale Introduction and Business Overview
7.3.3 Ceva Sante Animale Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Ceva Sante Animale Coccidiosis Treatment Product Offerings
7.3.5 Ceva Sante Animale Recent Development
7.4 Intas Pharmaceuticals Ltd.
7.4.1 Intas Pharmaceuticals Ltd. Company Information
7.4.2 Intas Pharmaceuticals Ltd. Introduction and Business Overview
7.4.3 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Product Offerings
7.4.5 Intas Pharmaceuticals Ltd. Recent Development
7.5 Jurox Pty Ltd.
7.5.1 Jurox Pty Ltd. Company Information
7.5.2 Jurox Pty Ltd. Introduction and Business Overview
7.5.3 Jurox Pty Ltd. Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Jurox Pty Ltd. Coccidiosis Treatment Product Offerings
7.5.5 Jurox Pty Ltd. Recent Development
7.6 Merck Animal Health
7.6.1 Merck Animal Health Company Information
7.6.2 Merck Animal Health Introduction and Business Overview
7.6.3 Merck Animal Health Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Merck Animal Health Coccidiosis Treatment Product Offerings
7.6.5 Merck Animal Health Recent Development
7.7 Vetoquinol S.A.
7.7.1 Vetoquinol S.A. Company Information
7.7.2 Vetoquinol S.A. Introduction and Business Overview
7.7.3 Vetoquinol S.A. Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Vetoquinol S.A. Coccidiosis Treatment Product Offerings
7.7.5 Vetoquinol S.A. Recent Development
7.8 Virbac S.A.
7.8.1 Virbac S.A. Company Information
7.8.2 Virbac S.A. Introduction and Business Overview
7.8.3 Virbac S.A. Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Virbac S.A. Coccidiosis Treatment Product Offerings
7.8.5 Virbac S.A. Recent Development
7.9 Zoetis, Inc.
7.9.1 Zoetis, Inc. Company Information
7.9.2 Zoetis, Inc. Introduction and Business Overview
7.9.3 Zoetis, Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Zoetis, Inc. Coccidiosis Treatment Product Offerings
7.9.5 Zoetis, Inc. Recent Development
7.10 Novartis Animal Healthcare
7.10.1 Novartis Animal Healthcare Company Information
7.10.2 Novartis Animal Healthcare Introduction and Business Overview
7.10.3 Novartis Animal Healthcare Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Novartis Animal Healthcare Coccidiosis Treatment Product Offerings
7.10.5 Novartis Animal Healthcare Recent Development
7.11 Smartvet Inc.
7.11.1 Smartvet Inc. Company Information
7.11.2 Smartvet Inc. Introduction and Business Overview
7.11.3 Smartvet Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Smartvet Inc. Coccidiosis Treatment Product Offerings
7.11.5 Smartvet Inc. Recent Development
7.12 Huvepharma
7.12.1 Huvepharma Company Information
7.12.2 Huvepharma Introduction and Business Overview
7.12.3 Huvepharma Coccidiosis Treatment Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Huvepharma Coccidiosis Treatment Product Offerings
7.12.5 Huvepharma Recent Development
8 Industry Chain Analysis
8.1 Coccidiosis Treatment Industrial Chain
8.2 Coccidiosis Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Coccidiosis Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Coccidiosis Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Coccidiosis Treatment Market Trends
Table 2. Coccidiosis Treatment Market Drivers & Opportunity
Table 3. Coccidiosis Treatment Market Challenges
Table 4. Coccidiosis Treatment Market Restraints
Table 5. Global Coccidiosis Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Coccidiosis Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Coccidiosis Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Coccidiosis Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Coccidiosis Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Coccidiosis Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Coccidiosis Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Coccidiosis Treatment
Table 13. Global Coccidiosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coccidiosis Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Coccidiosis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Coccidiosis Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Coccidiosis Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Coccidiosis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Coccidiosis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Coccidiosis Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Coccidiosis Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Coccidiosis Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Coccidiosis Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Coccidiosis Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Coccidiosis Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Coccidiosis Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Coccidiosis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Coccidiosis Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Coccidiosis Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Coccidiosis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Coccidiosis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Coccidiosis Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Coccidiosis Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Coccidiosis Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Coccidiosis Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Coccidiosis Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Coccidiosis Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Coccidiosis Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Coccidiosis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Coccidiosis Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Coccidiosis Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Coccidiosis Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Coccidiosis Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Coccidiosis Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Coccidiosis Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Coccidiosis Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Coccidiosis Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Coccidiosis Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Coccidiosis Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Coccidiosis Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Coccidiosis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Coccidiosis Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Coccidiosis Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Coccidiosis Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Coccidiosis Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. Bayer Animal Health Company Information
Table 58. Bayer Animal Health Introduction and Business Overview
Table 59. Bayer Animal Health Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Bayer Animal Health Coccidiosis Treatment Product Offerings
Table 61. Bayer Animal Health Recent Development
Table 62. Boehringer Ingelheim Vetmedica, Inc. Company Information
Table 63. Boehringer Ingelheim Vetmedica, Inc. Introduction and Business Overview
Table 64. Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Product Offerings
Table 66. Boehringer Ingelheim Vetmedica, Inc. Recent Development
Table 67. Ceva Sante Animale Company Information
Table 68. Ceva Sante Animale Introduction and Business Overview
Table 69. Ceva Sante Animale Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Ceva Sante Animale Coccidiosis Treatment Product Offerings
Table 71. Ceva Sante Animale Recent Development
Table 72. Intas Pharmaceuticals Ltd. Company Information
Table 73. Intas Pharmaceuticals Ltd. Introduction and Business Overview
Table 74. Intas Pharmaceuticals Ltd. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Intas Pharmaceuticals Ltd. Coccidiosis Treatment Product Offerings
Table 76. Intas Pharmaceuticals Ltd. Recent Development
Table 77. Jurox Pty Ltd. Company Information
Table 78. Jurox Pty Ltd. Introduction and Business Overview
Table 79. Jurox Pty Ltd. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Jurox Pty Ltd. Coccidiosis Treatment Product Offerings
Table 81. Jurox Pty Ltd. Recent Development
Table 82. Merck Animal Health Company Information
Table 83. Merck Animal Health Introduction and Business Overview
Table 84. Merck Animal Health Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Merck Animal Health Coccidiosis Treatment Product Offerings
Table 86. Merck Animal Health Recent Development
Table 87. Vetoquinol S.A. Company Information
Table 88. Vetoquinol S.A. Introduction and Business Overview
Table 89. Vetoquinol S.A. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Vetoquinol S.A. Coccidiosis Treatment Product Offerings
Table 91. Vetoquinol S.A. Recent Development
Table 92. Virbac S.A. Company Information
Table 93. Virbac S.A. Introduction and Business Overview
Table 94. Virbac S.A. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Virbac S.A. Coccidiosis Treatment Product Offerings
Table 96. Virbac S.A. Recent Development
Table 97. Zoetis, Inc. Company Information
Table 98. Zoetis, Inc. Introduction and Business Overview
Table 99. Zoetis, Inc. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Zoetis, Inc. Coccidiosis Treatment Product Offerings
Table 101. Zoetis, Inc. Recent Development
Table 102. Novartis Animal Healthcare Company Information
Table 103. Novartis Animal Healthcare Introduction and Business Overview
Table 104. Novartis Animal Healthcare Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Novartis Animal Healthcare Coccidiosis Treatment Product Offerings
Table 106. Novartis Animal Healthcare Recent Development
Table 107. Smartvet Inc. Company Information
Table 108. Smartvet Inc. Introduction and Business Overview
Table 109. Smartvet Inc. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Smartvet Inc. Coccidiosis Treatment Product Offerings
Table 111. Smartvet Inc. Recent Development
Table 112. Huvepharma Company Information
Table 113. Huvepharma Introduction and Business Overview
Table 114. Huvepharma Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Huvepharma Coccidiosis Treatment Product Offerings
Table 116. Huvepharma Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Coccidiosis Treatment Downstream Customers
Table 120. Coccidiosis Treatment Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Coccidiosis Treatment Product Picture
Figure 2. Global Coccidiosis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Coccidiosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Coccidiosis Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Coccidiosis Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Coccidiosis Treatment Report Years Considered
Figure 7. Global Coccidiosis Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Coccidiosis Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Coccidiosis Treatment Revenue in 2023
Figure 10. Coccidiosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Ionophore Drugs Picture
Figure 12. Antibiotic Drugs Picture
Figure 13. Chemical Derivative Drugs Picture
Figure 14. Global Coccidiosis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Coccidiosis Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Coccidiosis Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Coccidiosis Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Coccidiosis Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Poultry
Figure 20. Product Picture of Fish
Figure 21. Product Picture of Cattle
Figure 22. Global Coccidiosis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Coccidiosis Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Coccidiosis Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Coccidiosis Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Coccidiosis Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Coccidiosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Coccidiosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Coccidiosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Coccidiosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Coccidiosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Coccidiosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Coccidiosis Treatment Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Coccidiosis Treatment Sales Volume (%), (2019-2030)
Figure 39. United States Coccidiosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Coccidiosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Coccidiosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Coccidiosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. China Coccidiosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. China Coccidiosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Coccidiosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Coccidiosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Coccidiosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Coccidiosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Coccidiosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Coccidiosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 57. India Coccidiosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Coccidiosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 59. India Coccidiosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 60. Coccidiosis Treatment Industrial Chain
Figure 61. Coccidiosis Treatment Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
